Enerlabs, Inc. (ENLB: OTC Pink Current) | Enerlabs Signs

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Enerlabs, Inc. (ENLB: OTC Pink Current) | Enerlabs Signs Agreement to Purchase 3rd Laboratory Enerlabs Signs Agreement to Purchase 3rd Laboratory

Enerlabs Signs Agreement to Purchase 3rd Laboratory

PR Newswire

OKLAHOMA CITY , May 14, 2013 /PRNewswire/ -- Enerlabs, Inc. (OTC pink:ENLB), an energy & environmental laboratory company, announced today that it has signed an Asset Purchase Agreement to acquire a 3rd testing laboratory for $600,000.00 . Subject to financing, closing is anticipated within the next 90 days.

This laboratory specializes in hydrocarbon testing and is located in Oklahoma.  This laboratory is a full service analytical lab serving the areas and industries of petrochemical, petroleum products and refinery.  Employing ASTM and API approved methodology; their analysts provide data that assists clients in measuring their environmental impact, ensuring the efficiency of their processes and determining the quality of their products.

Further announcements will be forthcoming.

About Enerlabs, Inc.
The management of Enerlabs, Inc. has 25 years of experience working with public companies in the energy sector.  We are currently negotiating to combine our public resources with established laboratories that have experienced personnel, up-to-date equipment and a history of providing reliable service to their clients.  Our strategy is to gain certain advantages through networking the laboratories that participate such as, volume discount purchasing, shared software, combined accounting, group insurance and cross-over sales.  We look forward to initiating this business plan in 2013.  Please visit Enerlabs, Inc.'s website at www.enerlabsinc.com .

Safe Harbor for Forward-Looking Statements
Certain statements contained in this press release are forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause Enerlabs' actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Except as required by law, Enerlabs expressly disclaims any intent or obligation to update any forward-looking statements.

SOURCE Enerlabs, Inc.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Oscar Health Options Activity and Market Insights for Investors

Updated Category News Views 265

Understanding Oscar Health's Recent Options Activity In the fast-paced world of trading, Oscar Health Inc’s (NYSE: OSCR) recent options activity has captured significant attention among savvy investors. Notably, there has been a notable bullish sentiment from wealthy investors towards this health insurance company. Tracking public options data reveals movements that...

Continue Reading
Better Choice Company Finalizes Sale of Halo Asia Business

Updated Category News Views 160

Better Choice Company Settles on Halo Asia Sale Better Choice Company, Inc. (BTTR), a leader in pet health and wellness, has recently reached a significant milestone by signing a definitive agreement to sell its Halo business in Asia. This sale is projected to generate total gross proceeds of $8.1 million, which encompasses $6.5 million in cash at the closing of the deal....

Continue Reading
Fastenal Prepares for Earnings Report: What Investors Should Know

Updated Category News Views 154

Fastenal Prepares for Earnings Report Fastenal (NASDAQ: FAST) is gearing up to release its quarterly earnings report. Investors are keenly anticipating the upcoming announcement, as it offers a glimpse into the company's financial performance. This article provides essential insights and analysis for those eager to understand what to expect from Fastenal's announcement....

Continue Reading
Compass Therapeutics Takes Major Steps in Biliary Cancer Trials

Updated Category News Views 203

Compass Therapeutics Advances Cancer Research BOSTON — Compass Therapeutics, Inc. (Nasdaq: CMPX), a promising player in the biotechnology sphere focused on developing innovative therapies for cancer, has made significant strides in its clinical research. The company has announced that the first patient has been dosed in a groundbreaking Investigator Sponsored Trial...

Continue Reading
Understanding the Recent ECB Fine on LHV Group and Its Implications

Updated Category News Views 218

Overview of the ECB Fine Imposed on LHV Group The European Central Bank (ECB) has recently informed AS LHV Group about a decision to levy an administrative fine amounting to EUR 405 thousand. This fine is linked to an error identified in the consolidated regulatory reporting for a specified timeframe. The issue arose from discrepancies in how the equity of LHV Bank...

Continue Reading